Archil Jaliashvili: Biological Hemoglobin Oxygen Carriers as a Bridge in Emergencies
Archil Jaliashvili, Co-Chief Executive Officer at GeoBio Pharm, Biotech Executive, Strategic Partner of BHOC and Precision Oxygen Therapeutics, shared a post on LinkedIn:
”Biological Hemoglobin Oxygen Carriers (BHOCs) – a bridge in emergencies
When donor blood is not available or is not an option – and when conventional blood cannot adequately restore oxygen delivery at the tissue level.
This can happen for different reasons:
- Severe anemia
- Ischemia
- Myocardial infarction
- Stroke and other acute ischemic conditions
- Cardiac arrest
- Severe tissue hypoxia despite conventional treatment
The critical question is therefore not simply:
‘How much blood does the patient have’
It is:
‘Is enough oxygen actually reaching the tissues that need it?’
This is where Biological Hemoglobin Oxygen Carriers (BHOCs) could offer a fundamentally different approach.
- Not replacing blood.
- Not replacing donors.
But providing an additional way to deliver oxygen when donor red cells are unavailable, unsuitable, delayed-or when own blood alone may not be sufficient to oxygenate organs and tissues.
The objective is simple:
Get oxygen where and when it is needed.
And when time matters, create the time needed for definitive treatment. Time is life.”
Other posts featuring Archil Jaliashvili on Hemostasis Today.
-
Oct 13, 2026, 02:01Nour Al-Mozain: Is It Really Anti-D? – Unraveling Auto-Anti-LW in the Transfusion Laboratory
-
Oct 13, 2026, 01:51Berenice Villegas: The Role of Morphologic Evaluation in Body Fluid Differential Analysis
-
Oct 13, 2026, 01:44Debadrita Ray: Evaluating vWF and VITRO Score for Detecting CSPH in cACLD Patients
-
Oct 13, 2026, 01:34Nagesh Ramesh: Donating Blood for International Plasma Awareness Week
-
Oct 12, 2026, 21:51Sam Botchey: Orthobiologics Are Advancing but the Evidence Must Keep Pace
-
Oct 12, 2026, 21:50Serum Vitamin D, Platelet Function, and Bleeding in Primary ITP – Platelets Journal
-
Oct 12, 2026, 21:30Nika Samadzadeh Tabrizi: Looking Forward to the PACeS Trial on Anticoagulation for POAF
-
Oct 12, 2026, 21:28Michael Megaly: Does Coronary Ectasia Affect Outcomes in Acute Coronary Syndromes?
-
Oct 12, 2026, 21:25Vitor Borin P. de Souza: Think Twice Before Anticoagulating an Isolated Subsegmental PE